PARG and neoplasm: Biochemically, the combination of PARG inhibition and PARPi resistance models focus on basic aspects of the tumor, such as mitochondrial dynamics, ER/mitochondria interactions, and the use of lipids as fuel to adapt to oxidative stress or anaerobic glycolysis.